Esophageal Cancer Study: Using Noninvasive Tests to Guide Care
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a newly diagnosed esophageal or gastroesophageal junction tumor.
- You are scheduled for surgery to remove the cancer with the goal of cure.
- You have not yet received any chemotherapy, radiation, or other cancer treatments for this disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at past patients’ medical and pathology records from esophageal cancer surgeries. It may help improve how doctors understand which advanced tumors should be treated, by reviewing outcomes in specific tumor stages.
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
This study looks at how doctors use a special scope test (endoscopic ultrasound) to guide treatment decisions for people newly diagnosed with esophageal cancer. It aims to understand variations in care and improve future use of this test.
This study tests a new way to manage complications after esophageal cancer surgery using a special algorithm. The goal is to improve recovery and care for patients who have this surgery.
This trial looks at whether a personalized blood test can detect cancer returning after surgery for esophageal cancer. It tests people who had chemoradiotherapy before surgery and still had some cancer remaining in the removed tissue. The goal is to use the blood test to catch any remaining or returning cancer early.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
Hear when a new Esophageal Cancer (EsC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.